Company: VREOF
Filing Date: 2025-05-09
Form Type: DEF 14A
Source: 0001140361-25-018064
Chunk: 33

Company: Vireo Growth Inc.
Filing Date: 2025-05-09
Form: DEF 14A
Chunk 33
---

 Former Executive Vice President of Retail(6)                           |      |     | 2024 |         |     | 102,308 |         |     |  68,166 |   |     |         — |     |     | —            |         |     |   170,474 |
|                                                                        | 2023 |     |      | 200,000 |     |         |       — |     |         | — |     |           | 176 |     |              | 200,176 |     |           |

| (1) | Mr. Mazarakis was appointed as Co-Executive Chairman of the Board and Chief Executive Officer on December 17, 2024. |

| (2) | Ms. Shimpa served as Chief Executive Officer from October 10, 2024 to December 17, 2024. Ms. Shimpa currently serves as President of the Company. |

| (3) | Mr. Rosen resigned as Chief Executive Officer and interim Chief Financial Officer on October 10, 2024. |

| (4) | Mr. Macdonald was appointed as Chief Financial Officer on December 17, 2024. |

| (5) | Mr. Duxbury served as Chief Financial Officer from October 10, 2024 to December 17, 2024. Mr. Duxbury currently serves as Chief Accounting Officer of the Company. |

| (6) | Mr. Peters resigned as Executive Vice President of Retail of Vireo Health, Inc., a wholly-owned subsidiary of the Company, on June 14, 2024. |

| (7) | The amounts reported in the Option Awards column reflects aggregate grant date fair value computed in accordance with ASC Topic 718, Compensation—Stock Compensation. These amounts reflect our calculation of the value of these awards at the grant date and do not necessarily correspond to the actual value that may ultimately be realized by the NEO. The assumptions used in calculating the valuations are set forth in Note 17 to the Company’s Audited Financial Statements in the Company’s Annual Report. |

| (8) | The amounts reported in the Stock Awards column reflects aggregate grant date fair value of stock awards and RSUs computed in accordance with ASC Topic 718, Compensation—Stock Compensation. These amounts reflect our calculation of the value of these awards at the grant date and do not necessarily correspond to the actual value that may ultimately be realized by the NEO. The assumptions used in calculating the valuations are set